Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders

Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders

Article
Diseases & Conditions
Cancer & Benign Tumors
+3
Contributed byKrish Tangella MD, MBAApr 28, 2018

What are the other Names for this Condition? (Also known as/Synonyms)

  • AR-EBVLPD (Age-Related EBV-Associated B-Cell Lymphoproliferative Disorder)
  • Epstein-Barr Virus Infection causing Lymphoproliferative Disorders in Elderly
  • Senile Epstein-Barr Virus Associated B-Cell Lymphoproliferative Disorders

What is Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders? (Definition/Background Information)

  • Age-Related Epstein-Barr Virus Associated B-Cell Lymphoproliferative Disorders (AR-EBVLPDs) are rare cancer types, wherein the affected individuals have EBV positive lymphocytes
  • Lymphoproliferative disorders (LPDs) are disorders in which there is uncontrolled production of (excess) lymphocytes due to various reasons, chiefly from an immune-compromised state
  • These are aggressive, uncommon, and usually affect middle-aged and elderly adults. Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders originate within the lymph nodes, but frequently spread outside the lymph nodes
  • The cause of Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders is unknown. There are also no known risk factors or immunodeficient states associated with them; only an association with EBV infection is noted (which is a diagnostic criterion)
  • The treatment is targeted at the whole body and systemic therapy, such as chemotherapy, is provided. If the individual is relatively younger, then a bone marrow transplantation may be considered, if necessary
  • The prognosis of Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders is generally poor, due to an aggressive nature of the condition and complete involvement of the body systems and organs. The median survival period post-diagnosis is around 2 years

General information on lymphoma and lymphocytes:

  • Lymphoma is a type of cancer stemming from uncontrollably dividing lymphocytes (type of white blood cells). There are two types of lymphomas:
    • Hodgkin lymphoma
    • Non-Hodgkin lymphoma
  • Lymphocytes are the main white blood cells found in the lymph, which is the fluid of the lymphatic system; just as blood is the fluid of the circulatory system
  • Lymphocytes are made in bone marrow, and can develop into either B-cells or T-cells. Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders arises from cancerous B-cells
  • Lymph results from filtration of blood as it travels to and from tissues. Lymph is colorless because it lacks red blood cells; instead, it contains lymphocytes. It is central to the immune system
  • There are 3 different kinds of lymphocytes:
    • T-lymphocytes or T cells: They help combat infections and abnormalities within the cells (cell-mediated immunity). They fight viruses and cancerous cells
    • B-lymphocytes or B cells: They produce antibodies that are bodily defense proteins, which target foreign invaders outside the cells (humoral immunity). They fight bacterial cells, cell fragments, and other immunogenic elements
    • Natural killer cells or NK cells: They perform diverse functions related to both cell-mediated and humoral immunity. They also scout for cancer cells, a process called immune surveillance

Who gets Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders? (Age and Sex Distribution)

  • Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders are a set of infrequent disorders observed in adults, in the 45-100 years age range
  • The condition is usually seen in those over 50 years. Some studies show an overall median age of 75 years at presentation/diagnosis
  • The condition affects both males and females
  • All races and ethnic groups can be affected

What are the Risk Factors for Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders? (Predisposing Factors)

No specific risk factors have been identified for Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders. Research studies have also established the following factors in individuals with these disorders:

  • There is no prior history of lymphomas
  • There are no known immunodeficiency states, which come about due to various factors such as organ transplant, poorly-controlled diabetes, old age, etc.
  • There is no underlying condition that decreases immunity, such as an HIV infection

Nevertheless, in general, the following factors may contribute towards cancer formation and development.

  • Family history of immune disease
  • Age 60 years and older
  • Decreased immunity, especially due to HIV/AIDS
  • The presence of any systemic disease
  • Smoking
  • Exposure to radiation and industrial chemicals
  • Chemotherapy
  • Viruses (in some rare cases); Epstein-Barr virus infection
  • X-ray, CT scan exposure
  • Profession involving radiation exposure, which may include nuclear plant workers, pilots, astronauts, etc.
  • Certain medications and drugs

It is important to note that having a risk factor does not mean that one will get the condition. A risk factor increases ones chances of getting a condition compared to an individual without the risk factors. Some risk factors are more important than others.

Also, not having a risk factor does not mean that an individual will not get the condition. It is always important to discuss the effect of risk factors with your healthcare provider.

What are the Causes of Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders? (Etiology)

Lymphocytes are a type of white blood cells that are responsible for providing immunity in the human body. B-cells and T-cells are the two different types of lymphocytes. When under certain circumstances, the lymphocytes grow and multiply abnormally, it can result in lymphoproliferative disorders.

  • The cause of Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders is unknown
  • However, there is an association of the condition with Epstein-Barr virus (EBV)

Also, there may be certain genetic defects, such as translocation, which is a juxtaposition of regions of the chromosomes. This may result in:

  • Change of regulatory elements of certain cancer-causing genes called as oncogenes, which can lead to increased production of their mRNA (overexpression), thus increasing their protein levels
  • Exchange of protein coding regions of gene, giving rise to new proteins that can stimulate the inappropriate growth of cells

It is believed that the abnormal development of lymphocytes gives rise to cancerous cells leading to the formation of this condition. Nevertheless, how this occurs and the factors that cause it remain under investigation.

What are the Signs and Symptoms of Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders?

The general signs and symptoms of Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders include:

  • Enlarged lymph nodes
  • Unintentional weight loss; changes in appetite
  • Fatigue and weakness, headache
  • High temperatures and excessive night sweats (may be recurrent)
  • Anemia (low red blood cell count)
  • Frequent infections
  • Trouble breathing
  • Low blood pressure
  • Back pain
  • Swelling of the legs
  • Abdominal pain and swelling; constipation
  • Frequent urination

Involvement of organs, such as the spleen, liver, thyroid gland, bone, breast, testes, gastrointestinal tract, and skin may occur, which can result in associated signs and symptoms. Depending upon the specific organ or area involved, the signs and symptoms may include:

  • Associated autoimmune disorders, which can cause joint and muscle pain, heat intolerance, recurrent rashes, abdominal pain, and a general feeling of illness
  • If the brain is involved, then neurological symptoms such as the following may be observed:
    • Confusion
    • Tinnitus (ringing in the ears)
    • Hearing and visual impairment
  • If the gastrointestinal (GI) tract is involved, then GI tract symptoms such as the following may be observed:
    • Ulcers
    • Diarrhea
    • Inflammation
    • GI bleeding
  • Liver and spleen enlargement
  • Joint inflammation and fluid accumulation (edema) can occur, if the joints are affected
  • The tumor can affect the bones and result in easy fractures

How is Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders Diagnosed?

The diagnostic criteria for Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders are as follows:

  • Age above 50 years
  • No history of immunodeficiency
  • Presence of EBV in the lymphocytes
  • Exclusion of other B-cell lymphomas

The following methods may aid in the study-diagnosis of AR-EBVLPD:

  • A thorough physical examination and a complete medical history, which is very important
  • Blood tests that include:
    • Complete blood cell count (CBC) blood test
    • Chemistry panel
    • Serum calcium levels
    • Serum lactodehydrogenase (LDH) level
    • Serum albumin levels
    • Blood urea nitrogen (BUN)
    • HIV testing
    • Absolute lymphocyte count on peripheral blood
    • Some individuals have increased number of eosinophils in peripheral blood
  • Since the cancer involves the lymph nodes, biopsies of enlarged lymph nodes are taken and examined in a lab to determine if the cells are malignant or benign. The biopsies may be performed under general or local anesthesia. Normally, the entire lymph node is removed
  • A biopsy may be obtained from the affected area
    • A biopsy of the tumor is performed and sent to a laboratory for a pathological examination. A pathologist examines the biopsy under a microscope. After putting together clinical findings, special studies on tissues (if needed) and with microscope findings, the pathologist arrives at a definitive diagnosis. Examination of the biopsy under a microscope by a pathologist is considered to be gold standard in arriving at a conclusive diagnosis
    • Biopsy specimens are studied initially using Hematoxylin and Eosin staining. The pathologist then decides on additional studies depending on the clinical situation
    • Sometimes, the pathologist may perform special studies, which may include immunohistochemical stains, molecular testing, flow cytometric analysis and very rarely, electron microscopic studies, to assist in the diagnosis
  • Radiological imaging may be performed to determine the extent of cancer in the body including:
    • X-ray of the affected region
    • Ultrasound scan of the affected region
    • Computerized tomography (CT) scan of the affected region
    • Vascular radiological studies
    • Whole body bone scan
    • Whole body CT-PET scans to determine how far the malignancy has spread, by checking the size and metabolic rate (a reflection of uncontrolled growth) of lymph nodes, throughout the body. This can also help determine, if the cancer has spread to other organ systems
    • Brain MRIs are used if neurological symptoms are present, which can help determine if the cancer has spread to the brain, or to tissues that cover the brain
  • Bone marrow aspiration and biopsy is performed and sent to a laboratory for a pathological examination, to determine if the bone marrow is involved. Sometimes, the pathologist may perform special studies, which may include immunohistochemical stains, histochemical stains, molecular testing, and very rarely electron microscopic studies. However, a bone marrow biopsy is not needed in the early stages of the condition
  • Flow cytometry (analysis of blood and/or tissue) to identify cells as they flow through an instrument, called a flow cytometer. Flow cytometry measures the number and percentage of cells in a blood sample, and cell characteristics such as size, shape, and the presence of biomarkers on the cell surface. This method helps to sub-classify the condition and also to detect residual levels of disease after treatment. This tool can help in diagnosing relapse and restart treatment as needed
  • Fluorescence in situ hybridization (FISH): It is a test performed on the blood or bone marrow cells to detect chromosome changes (cytogenetic analysis) in blood cancer cells. The test helps in identifying genetic abnormalities that may not be evident with an examination of cells under a microscope
  • Immunophenotyping to identify a specific type of cell in a sample, which can help determine the best treatment course to be followed
  • Polymerase chain reaction (PCR): It is used to measure the presence of certain biomarkers in blood or bone marrow cells. The test is ultrasensitive and detects extremely low amounts of biomarkers remaining in blood, which can be missed by cytogenetic methods, such as FISH, karyotype, or flow cytometry. PCR allows a more sensitive follow-up of patients in remission and can help determine whether additional treatment is necessary
  • Tests to examine central nervous system (CNS) involvement, if any
  • GI endoscopy: It may be performed to assess the extent of cancer spread
  • Multigated acquisition (MUGA) scan or echocardiography to identify cardiotoxicity as a result of chemotherapy
  • Liver function test (LFT) and liver biopsy
  • Pulmonary function test (PFT)
  • Exploratory laparoscopy (diagnostic laparoscopy) may be required, if gastrointestinal symptoms are present. In this procedure, the abdomen is examined using a minimally-invasive technique, and a tissue biopsy and tissue for culture obtained. Minimally-invasive approaches help decrease complications and the length of stay at the hospital. A diagnostic laparoscopy is also helpful in staging of the tumor. Nevertheless, this procedure is not very much used

Many clinical conditions may have similar signs and symptoms. Your healthcare provider may perform additional tests to rule out other clinical conditions to arrive at a definitive diagnosis.

What are the possible Complications of Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders?

The complications due to Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders may include the following:

  • Involvement of local and distant organs and loss of function of the organ/area to which the cancer has spread
  • Weakened immune system (or immunosuppression) can be a complication, which can become more severe during treatment. Due to this, individuals are more vulnerable to infections; there is an increased risk of developing serious complications from such infections
  • If the condition spreads to the brain and central nervous system, it can give rise to:
    • Inflammation of the meninges or brain (that can be lethal)
    • Headache
    • Vision changes
    • Facial numbness
  • If the abdomen is affected, it can cause intestinal obstruction that results in urine outflow obstruction and kidney damage
  • Blood loss may occur due to frequent or heavy bleeding, giving rise to severe anemia
  • The leukemic cells can overgrow and cause clogging of vessels resulting in stroke, or blurring of vision

There may be complications related to chemotherapy used in treating the condition, which may include:

  • Side effects such as dizziness, vomiting, appetite loss, mouth ulcers, and hair loss
  • By damaging healthy cells, the individual is more open or vulnerable to secondary infections
  • The treatment can also cause infertility in men and women. Hence, measures to protect the individual’s fertility must be considered, before starting chemotherapy
  • Tumor lysis syndrome: This can occur due to chemotherapy treatment and can result in kidney failure, if not recognized promptly

How is Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders Treated?

Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders are a group of aggressive cancers that require prompt treatment for systemic signs and symptoms following its diagnosis. Once a definitive diagnosis has been made, staging is used to describe how far the cancer has spread. The stage can help describe:

  • How many lymph nodes are affected
  • Their locations in the body
  • And, if other organs are being affected

Staging is important because different treatment regimens are necessary, depending on the progression of LPD. These may be classified as:

  • Stage 1: Only one group of lymph nodes in one location is affected
  • Stage 2: Lymph nodes in multiple locations that are all above or below the diaphragm are affected
  • Stage 3: Lymph nodes in multiple locations, both above and below the diaphragm are affected
  • Stage 4:  Lymph nodes located throughout the body, the bone marrow, and other organs are affected

Systemic therapy is generally required for malignant and advanced stage cancers. A combination of treatment measures may be effectively used to treat the condition. It may include the following:

  • Chemotherapy: This approach uses a combination of drugs to kill the cancerous cells and can be used in patients, for all stages of the cancer
    • There can be severe side effects including fatigue, nausea, hair loss, anemia, high risk of infection, and drug-specific reactions
    • Many cancers are resistant to chemotherapy. It can also damage healthy cells
    • Chemotherapy can be administered as a pill, liquid, shot, or intravenously

Note: Men and women in child-bearing age would greatly benefit from counseling regarding fertility issues. Some chemotherapy agents can cause infertility in both men and women. There can be permanent damage to the testicles and ovaries, harming their ability to produce sperms or ova. In men, sperm banking can be considered before initiating therapy. In women, in many cases, due to urgency of starting chemotherapy, it is often difficult to perform ovum banking. However, if there is sufficient time prior to chemotherapy, ovum banking may be performed. The healthcare provider may help assess the risk-benefit analysis, depending upon each individual’s specific circumstances.

  • Surgery: After initial biopsies to diagnose the condition, surgery is a very uncommon treatment option, because AR-EBVLPDs are systemic and might have already spread to more than one lymph node in most patients. Under such circumstances, removing all the affected lymph nodes would be extremely difficult
  • Radiation therapy is generally not used to treat the condition
  • Intrathecal chemotherapy, if there is an involvement of the brain
  • Supportive treatment: Steroids, blood transfusions, anti-nausea medications, and antibiotics, may be used as supportive therapy. In combination with other treatment measures, these can help combat the symptoms of immunodeficiency, on a case-by-case basis

If Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders are not fully responsive to treatment, or if the chance of recurrence is high, then bone marrow transplantation or stem cell transplantation can be considered depending on each individual’s specific circumstances. Generally, these procedures may be undertaken if the patient is relatively younger.

  • Bone marrow transplantation: Typically systemic cases may be treated by administering high doses of chemotherapy or radiotherapy. But, high doses of chemotherapy drugs will also damage the bone marrow, preventing it from making any blood cells. Hence, before starting high-dose chemotherapy, the physicians may take out some of the patient’s bone marrow and freeze/preserve it. Collecting the bone marrow is called a bone marrow harvest. The bone marrow is then stored. After high dose chemotherapy or radiation, the bone marrow is thawed and injected back into patient through a drip (transfusion). This is called an autologous bone marrow transplant. Sometimes bone marrow donated by another matching person (usually a brother or sister) is used, if the condition recurs following transplant using one’s own cell. This is called as allogeneic bone marrow transplant
  • Stem cell transplantation: This procedure is similar to bone marrow transplantation and involves the transplantation of healthy blood-forming stem cells into the body. The procedure is also called hematopoietic progenitor cell transplantation. Stem cells can be collected from the bone marrow, circulating (peripheral) blood, and umbilical cord blood. It may either involve an autologous stem cell transplantation, where stem cells are harvested from individuals before treatment and transplanted back into the patient after treatment, or involve an allogeneic stem cell transplantation, where stem cells donated by another matching person (usually a brother or sister) is used, if the condition recurs after stem cell transplant using one’s own cell. This is called as allogeneic stem cell transplant

Note: Allogeneic bone marrow and allogeneic stem cell transplants may have more side effects and complications, and this treatment may not be suitable for every individual. If allogeneic transplants come from a healthy donor with no malignant cells, then the chances of recurrence of the condition may be reduced.

  • In order to prevent infections because the immune system is weakened by Senile EBV-Associated B-Cell Lymphoproliferative Disorders or by its treatment, the patient is kept in an isolated ward and treated with appropriate antibiotics
  • Nowadays, targeted therapies are being developed, that can selectively kill the lymphoma/leukemia cells. Many of them are in the stage of clinical trials
  • Clinical trials: There may be some newer treatment options, currently on clinical trials, which can be considered for some patients depending on their respective risk factors

Your healthcare provider will determine the best course of treatment depending on your individual circumstances. Also, follow-up care with regular screening and check-ups are important post-treatment.

How can Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders be Prevented?

Presently, the cause of Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders is unknown and there are no known methods to prevent their occurrence. Eliminating certain risk factors for cancer development may help avoid the condition. These factors include:

  • Healthy diet and exercise, as well as avoidance of unnecessary exposure to chemicals, may help decrease its risk
  • Avoidance or cessation of smoking
  • Undertaking appropriate and prompt treatment for any viral infections or other disorders
  • Using appropriate protective gear while working with x-rays and other radioactive source
  • In order to avoid a relapse, or be prepared for a recurrence, the entire diagnosis, treatment process, drugs administered, etc. should be well-documented and follow-up measures initiated

Regular medical screening at periodic intervals with blood tests, scans, and physical examinations, are mandatory. Often several years of active vigilance are crucial and necessary.

What is the Prognosis of Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders? (Outcomes/Resolutions)

  • Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders are highly-malignant cancers with high mortality rates. The median survival period following diagnosis is around 2 years
  • The prognosis depends upon a set of several factors, which include:
    • Stage of tumor: With lower-stage tumors, when the tumor is confined to site of origin, the prognosis is usually excellent with appropriate therapy. In higher-stage tumors, such as tumors with metastasis, the prognosis is poor
    • Overall health of the individual: Individuals with overall excellent health have better prognosis compared with those with poor health
    • Age of the individual: Older individuals generally have poorer prognosis than younger individuals
    • The size of the tumor: Individuals with small-sized tumors fare better than those with large-sized tumors
    • Individuals with bulky disease have a poorer prognosis
    • Involvement of vital organs may complicate the condition
    • The surgical respectability of the tumor (meaning, if the tumor can be removed completely) - it is a rare option
    • Whether the tumor is occurring for the first time, or is a recurrent tumor. Recurring tumors have worse prognosis compared to tumors that do not recur
    • Response to treatment: Tumors that respond to treatment have better prognosis compared to tumors that do not respond to treatment
    • Progression of the condition makes the outcome worse (progressive condition)
  • An early diagnosis and prompt treatment of the tumor generally yields better outcomes than a late diagnosis and delayed treatment
  • The combination chemotherapy drugs used, may have some severe side effects (such as cardio-toxicity). This chiefly impacts the elderly adults, or those who are already affected by other medical conditions. Tolerance to the chemotherapy sessions is a positive influencing factor
  • Progression to bone marrow failure is usually associated with short survival

Additional and Relevant Useful Information for Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders:

  • Treatment for Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders can cause physical and emotional distress; supportive care and encouragement, help positively and can bring a measure of relief to the patients

The following article link will help you understand leukemia and lymphoma (blood cancer):

http://www.dovemed.com/diseases-conditions/leukemia-and-lymphoma/

Was this article helpful

On the Article

Krish Tangella MD, MBA picture
Approved by

Krish Tangella MD, MBA

Pathology, Medical Editorial Board, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!